Anne Breggia, PhD, is a molecular biologist and translational research scientist who joined MaineHealth in 1991, serving for 20 years as a histocompatibility specialist and laboratory supervisor for the solid organ transplant program. In 2008, she was recruited as the Research Program Director of the BioBank and Research Laboratory Services core and, in 2021, she was recruited as the Director of the Center for Applied Science and Technology. Before joining MaineHealth, she held clinical laboratory scientist and management positions at the Foundation for Blood Research, Scarborough, ME, and the American Red Cross, Portland, ME. In her current position, she oversees and directs the research and development of new technologies to be put into the practice of medicine for improved patient care. Dr. Breggia received her PhD in Biochemistry and Molecular Biology from the University of Maine, Orono, and is board-certified as a Clinical Laboratory Scientist by the American Society of Clinical Pathologists (CLS, ASCP) and as a Histocompatibility Specialist by the American Board of Histocompatibility and Immunogenetics (CHS, ABHI). She served as co-investigator of the NIH/National Children’s Study Formative Research Proposal and as Principal Investigator of The Cancer Genome Atlas (TCGA); she is currently the NCORP site Principal Investigator for the NIH Cancer Moonshot Biobank study. Her current research is focused on cancer etiology and therapeutics.
Anne Breggia, PhD, is a molecular biologist and translational research scientist who joined MaineHealth in 1991, serving for 20 years as a histocompatibility specialist and laboratory supervisor for the solid organ transplant program. In 2008, she was recruited as the Research Program Director of the BioBank and Research Laboratory Services core and, in 2021, she was recruited as the Director of the Center for Applied Science and Technology. Before joining MaineHealth, she held clinical laboratory scientist and management positions at the Foundation for Blood Research, Scarborough, ME, and the American Red Cross, Portland, ME. In her current position, she oversees and directs the research and development of new technologies to be put into the practice of medicine for improved patient care. Dr. Breggia received her PhD in Biochemistry and Molecular Biology from the University of Maine, Orono, and is board-certified as a Clinical Laboratory Scientist by the American Society of Clinical Pathologists (CLS, ASCP) and as a Histocompatibility Specialist by the American Board of Histocompatibility and Immunogenetics (CHS, ABHI). She served as co-investigator of the NIH/National Children’s Study Formative Research Proposal and as Principal Investigator of The Cancer Genome Atlas (TCGA); she is currently the NCORP site Principal Investigator for the NIH Cancer Moonshot Biobank study. Her current research is focused on cancer etiology and therapeutics.